Summaries of health policy coverage from major news organizations
Three U.S. Drug Companies to Offer Discounted AIDS Drugs to Zambia
Zambian Health Minister Enock Kavindele announced yesterday that GlaxoSmithKline, Bristol-Myers Squibb and Merck & Co. have offered to "slash" the prices of antiretroviral drugs used in the sub-Saharan country if Zambia agrees to keep the drugs from being
smuggled out to other nations, Agence
France-Presse reports. Kavindele said the government will "make sure" none of the drugs are illegally exported in order to retain the offer. He said the offer came from the "goodwill" of the American companies and added that it might be extended to
Botswana, which has the world's highest rate of HIV infection. The price of the drugs would be reduced so that a day of treatment would cost about two dollars per person, still an "enormous expense for the average person in Zambia," one of the world's poorest countries (Agence-France Presse, 4/18).
This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.